Leading the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1 and Sandhoff diseases

Latest News

April 2022 Community News
Read NTSAD's latest e-newsletter! Sign up to receive next month's at the bottom of the home page. Read More
Sio GM1 and GM2 Clinical Trials News
Sio terminates licensing agreement. Read the joint statement from NTSAD and fellow patient advocacy groups and foundations. Read More
2022 Conference: Register Now!
Join the NTSAD Community in Denver, Colorado July 7-10! Apply for a Helping Hand Grant. Read More

› ‹

News

News Feeds

Details: Last Updated: Monday, 18 November 2019 10:26

A collection of news from www.news-medical.net, an Internet resource.

News Feed: Tay-Sachs

Latest Tay Sachs Disease News and Research

Using genetic screening for selecting the 'best' embryo in IVF
Each year, tens of thousands of babies are born in the United States as the result of IVF (in vitro fertilization) – where several eggs are fertilized outside the mother's body and then an embryo is selected for transfer into her womb.
A new combination therapy for treating rare, fatal Sanfilippo syndrome in children
A study aiming to develop a new therapeutic technique could bring a revolution in our approach to treating rare, fatal Sanfilippo syndrome, a disorder that affects children as young as 2 years old and leads to childhood dementia and premature death.
Study underscores the need for more precise rare disease definitions
Some diseases are like black swans. They occur so rarely that many physicians never encounter them in their clinical practice, complicating efforts to treat them.

News Feed: Sandhoff

Latest Sandhoff Disease News and Research

A new combination therapy for treating rare, fatal Sanfilippo syndrome in children
A study aiming to develop a new therapeutic technique could bring a revolution in our approach to treating rare, fatal Sanfilippo syndrome, a disorder that affects children as young as 2 years old and leads to childhood dementia and premature death.
New drug lures stem cells to damaged tissue, improves treatment efficacy
Scientists at Sanford Burnham Prebys Medical Discovery Institute have created a drug that can lure stem cells to damaged tissue and improve treatment efficacy--a scientific first and major advance for the field of regenerative medicine.
Gene therapy is the best stratagem to impact the course of GM2 gangliosidosis
Since its clinical description in 1881, Tay-Sachs disease has had almost totemic significance as a cruel and relentless genetic condition that destroys the developing brain of babies and young children.

News Feed: Canavan Disease

Latest Canavan Disease (Leukodystrophies) News and Research

Human stem cells show promise against fatal children's diseases
Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell.

Back Issues

Visit our library of eNews for copies of past newsletters, research updates, topics of the week and more

News Feed: DNA Science

Geneticist Ricki Lewis blogs from the cutting edge of genomics, including genetic testing, stem cells, gene therapy and more.

17 Timepoints When a Human Life Might Begin, 2022 Version

I originally published When Does a Human Life Begin? 17 Timepoints here at DNA Science in 2013. My intent was to inform…

The post 17 Timepoints When a Human Life Might Begin, 2022 Version appeared first on DNA Science.
The Utter Oddness of COVID Anosmia

The sudden inability to smell and taste that comes with COVID is startling and difficult to describe. I was lucky to experience…

The post The Utter Oddness of COVID Anosmia appeared first on DNA Science.
Probing the Genomes of the Roma, the Forgotten Europeans

The Roma people have long held a special fascination for population geneticists who study the frequencies of genetic diseases. The largest minority…

The post Probing the Genomes of the Roma, the Forgotten Europeans appeared first on DNA Science.

News Feed: Gangliosidosis-1

Latest Gangliosidosis News and Research

Gene therapy is the best stratagem to impact the course of GM2 gangliosidosis
Since its clinical description in 1881, Tay-Sachs disease has had almost totemic significance as a cruel and relentless genetic condition that destroys the developing brain of babies and young children.
New gene therapy shows promising results for treating neurodegenerative disorders
A new gene therapy approach designed to replace the enzyme that is deficient in patients with the inherited neurodegenerative disorders Tay-Sachs and Sandhoff diseases successfully delivered the therapeutic gene to the brains of treated mice, restored enzyme function, and extended survival by about 2.5-fold.
Researchers devise new genetic technique for IVF embryos
Researchers at the Johns Hopkins University School of Medicine have devised a new technique, which helps couples that are affected by or are carriers of genetic diseases have in vitro fertilized babies free of both the disease in question and other chromosomal abnormalities. The results were reported in the April issue of Fertility and Sterility.

Latest News

April 2022 Community News

Sio GM1 and GM2 Clinical Trials News

2022 Conference: Register Now!

News

News Feeds

A collection of news from www.news-medical.net, an Internet resource.

News Feed: Tay-Sachs

News Feed: Sandhoff

News Feed: Canavan Disease

Back Issues

News Feed: DNA Science

News Feed: Gangliosidosis-1

NTSAD

2001 Beacon Street
Suite 204

Boston, MA 02135

(617) 277-4463

Follow NTSAD

Twitter

Facebook

YouTube

LinkedIn

Ask us how you can join the fight.

info@ntsad.org

Login